InvestorsHub Logo
Followers 2
Posts 740
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Wednesday, 06/22/2016 9:18:34 AM

Wednesday, June 22, 2016 9:18:34 AM

Post# of 195026

According to the latest financial report, the controlling shareholder at the moment is called Armen Karapetyan. He was once at the helm of Basis Financial, LLC – a broker dealer based in Florida. While he was there, he started receiving a monthly fee of $5,000 from Pharmco (one of RXMD's current subsidiaries) for “ongoing investor awareness and business advisory services” and he later persuaded sixteen investors to pour $500 thousand into the company. Sadly, he forgot to disclose some important information about Pharmco, like, for example, the figures in the financial statement. More details about this, as well as a few other actions performed by Mr. Karapetyan while he was working for Basis can be read in this settlement agreement with FINRA.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News